47 reports

  • 8.3.4. UNLIKELY CANDIDATES FOR DELIVERY VIA AUTOINJECTORS

IT IS REPORTED TO BE MORE PREVALENT THAN DIABETES, EPILEPSY AND ASTHMA COMBINED.

  • Arthritis
  • Neurological Disorder
  • World
  • Forecast
  • Antares Pharma, Inc.

It is also being evaluated for the treatment of Crohn' s disease, psoriatic arthritis, and asthma.

  • Arthritis
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.

Rheumatoid arthritis

4546 5000 3864
  • PREVALENCE OF SELECTED CO-MORBIDITIES REPORTED IN THE INTERNATIONAL COMORA STUDY, BY REGION, 2014

In this study, patients were randomized ##:##:##:##:## to receive once-daily doses of placebo or ##mg, ##mg, ##mg, or ##mg baricitinib for ##weeks.

  • Arthritis
  • Japan
  • United States
  • Pfizer Inc.
  • Roche Group
  • SWITZERLAND HIP RECONSTRUCTION DEVICES MARKET, BY SURGERY TYPE,
  • 18.1 INTRODUCTION

IN THE U. K., ## IN ## WOMEN AND ## IN ## MEN SUFFER FRACTURES AFTER THE AGE OF ##.

  • Arthritis
  • Forecast
  • Market Size
  • Smith & Nephew Plc
  • Zimmer Biomet Holdings, Inc.
  • 18.1 INTRODUCTION
  • SWITZERLAND HIP RECONSTRUCTION DEVICES MARKET, BY SURGERY TYPE,

IN THE U. K., ## IN ## WOMEN AND ## IN ## MEN SUFFER FRACTURES AFTER THE AGE OF ##.

  • Arthritis
  • South America
  • Forecast
  • Market Size
  • Zimmer Biomet Holdings, Inc.
  • CANADA: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • US: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD BILLION)

Glucagon-like peptide-##, commonly known as GLP-##, is a hormone produced by the proglucagon gene in the L-cells of the gut.

  • Arthritis
  • Diabetes
  • Injectable Delivery
  • United States
  • Amgen Inc.
  • Alphavirus Infections
  • PIPELINE BY PARADIGM BIOPHARMACEUTICALS LTD, H1 2018

Also presented today are the results of a Phase ## study conducted in healthy subjects.

  • Arthritis
  • Chronic Pain
  • Australia
  • United States
  • World
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H2 2017
  • PIPELINE BY PARADIGM BIOPHARMACEUTICALS LTD, H2 2017

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Arthritis
  • Clinical Trial
  • Therapy
  • World
  • Galapagos NV
  • Alphavirus Infections
  • Pipeline by Paradigm Biopharmaceuticals Ltd, H1 2018

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Arthritis
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Arthritis
  • Cardiovascular Drug
  • Hepatitis
  • Therapy
  • Can-Fite BioPharma Ltd.

It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases.

  • Arthritis
  • Cancer
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • REJOIN - DRUG PROFILE
  • OSTEOARTHRITIS - DORMANT PROJECTS, H1 2018 (CONTD..4), H1 2018

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Arthritis
  • Cell Therapy
  • United States
  • Product Initiative
  • Amgen Inc.

Neurim offers treatments for other therapeutic areas that include Parkinson' s disease, and asthma or chronic obstructive pulmonary disease.

  • Arthritis
  • Pain Relief
  • Research And Development
  • Therapy
  • Flex Pharma, Inc.

The molecules developed by Companies in Phase III, Phase II and Phase I stages are ##, ## and ## respectively.

  • Arthritis
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • Number of Products under Development by Indication, H2 2017
  • Pipeline by Paradigm Biopharmaceuticals Ltd, H2 2017

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Arthritis
  • Clinical Trial
  • Therapy
  • Australia
  • Product Initiative
  • DORMANT PRODUCTS, H2 2017 (CONTD..4), H2 2017
  • PIPELINE BY PFIZER INC, H2 2017

The small molecules were also under development for asthma and rheumatoid arthritis.

  • Arthritis
  • Chronic Disease
  • Therapy
  • United States
  • Product Initiative
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017
  • Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Dormant Products

It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases.

  • Arthritis
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.

Regeneron also has various product candidates under clinical development for treating asthma, pain, cancer, atopic dermatitis and infectious diseases.

  • Arthritis
  • Chronic Pain
  • World
  • Product Initiative
  • Pfizer Inc.
  • R&D Progress
  • R&D Progress

The primary outcome measure of the study is to assess the improvement in the severity of asthma as measured by change in the asthma control questionnaire (ACQ) score.

  • Arthritis
  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States
  • INNOVIMMUNE BIOTHERAPEUTICS INC
  • INV-88 - DRUG PROFILE

Secondary endpoints include asthma exacerbation rate and the degree of asthma symptom control.

  • Arthritis
  • Cell Therapy
  • United States
  • Product Initiative
  • Anavex Life Sciences Corp.
  • Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Dormant Products
  • Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Dormant Products

Encore presentation from the WCOG at ACG2017 ##.

  • Arthritis
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.
  • R&D Progress
  • DALAZATIDE - DRUG PROFILE

AbbVie is also evaluating the potential of this biologic in Crohn' s disease, psoriatic arthritis, and asthma.

  • Arthritis
  • Autoimmune Disease
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Clinical Trial profile. 274 Trial Title
  • Clinical Trial Profile Snapshots

Patients were randomized to one of three treatment groups (##:##:##) and received either a single IA injection of ZILRETTA (## mg), normal saline-placebo or triamcinolone acetonide in crystalline suspension (TAcs) (## mg).

  • Arthritis
  • Clinical Trial
  • Musculoskeletal Disorder
  • Opioid
  • Pain Therapeutics
  • PIPELINE BY REGENERON PHARMACEUTICALS INC, H2 2017

Regeneron is also developing various product candidates in clinical development for treating asthma, pain, cancer, atopic dermatitis and infectious diseases.

  • Arthritis
  • Chronic Pain
  • United States
  • World
  • Pfizer Inc.
  • SYNTHETIC PEPTIDES FOR ALLERGIC ASTHMA AND RHEUMATOID ARTHRITIS - DRUG PROFILE
  • SODIUM HYPOCHLORITE - DRUG PROFILE

Rheumatoid Arthritis - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H2 2017, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape. Rheumatoid arthritis...

  • Arthritis
  • Pathology
  • Therapy
  • United States
  • Pfizer Inc.

ABBVIE IS ALSO EVALUATING THE POTENTIAL OF THIS BIOLOGIC IN CROHN' S DISEASE, PSORIATIC ARTHRITIS, AND ASTHMA.

  • Arthritis
  • Biotech
  • United States
  • Company
  • Company Operations
  • Flexion Therapeutics Inc - Opportunities

The inflammatory disease market is highly diverse and includes osteoarthritis, inflammatory bowel diseases, RA, chronic obstructive pulmonary disease (COPD), asthma, and psoriasis.

  • Arthritis
  • Therapy
  • United States
  • Company Financials
  • Flexion Therapeutics, Inc.
  • Rheumatoid Arthritis

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ## and ## respectively.

  • Arthritis
  • Therapy
  • World
  • Product Initiative
  • Can-Fite BioPharma Ltd.

It targets JAK ##.

  • Arthritis
  • Digestive System Disorder
  • Company
  • Product Initiative
  • Galapagos NV
  • OSTEOARTHRITIS - PIPELINE BY ORTHOCYTE CORP
  • OSTEOARTHRITIS - PIPELINE BY ONO PHARMACEUTICAL CO LTD

The company has expertise in the areas of cardiovascular, asthma, diabetology, pediatrics, central nervous system, anti-infectives, NSAIDs, anti-TB and cephalosporins.

  • Arthritis
  • United States
  • Company
  • Product Initiative
  • Amgen Inc.